Menu
GWAS Study

GWAS of thyroid stimulating hormone highlights pleiotropic effects and inverse association with thyroid cancer.

Zhou W, Brumpton B, Kabil O et al.

32769997 PubMed ID
GWAS Study Type
119715 Participants
Scroll to explore
Chapter I

Publication Details

Comprehensive information about this research publication

Authors

ZW
Zhou W
BB
Brumpton B
KO
Kabil O
GJ
Gudmundsson J
TG
Thorleifsson G
WJ
Weinstock J
ZM
Zawistowski M
NJ
Nielsen JB
CL
Chaker L
MM
Medici M
TA
Teumer A
NS
Naitza S
SS
Sanna S
SU
Schultheiss UT
CA
Cappola A
KJ
Karjalainen J
KM
Kurki M
OM
Oneka M
TP
Taylor P
FL
Fritsche LG
GS
Graham SE
WB
Wolford BN
OW
Overton W
RH
Rasheed H
HE
Haug EB
GM
Gabrielsen ME
SA
Skogholt AH
SI
Surakka I
DS
Davey Smith G
PA
Pandit A
RT
Roychowdhury T
HW
Hornsby WE
JJ
Jonasson JG
SL
Senter L
LS
Liyanarachchi S
RM
Ringel MD
XL
Xu L
KL
Kiemeney LA
HH
He H
NR
Netea-Maier RT
MJ
Mayordomo JI
PT
Plantinga TS
HJ
Hrafnkelsson J
HH
Hjartarson H
SE
Sturgis EM
PA
Palotie A
DM
Daly M
CC
Citterio CE
AP
Arvan P
BC
Brummett CM
BM
Boehnke M
DL
de la Chapelle A
SK
Stefansson K
HK
Hveem K
WC
Willer CJ
ÅB
Åsvold BO
Chapter II

Abstract

Summary of the research findings

Thyroid stimulating hormone (TSH) is critical for normal development and metabolism. To better understand the genetic contribution to TSH levels, we conduct a GWAS meta-analysis at 22.4 million genetic markers in up to 119,715 individuals and identify 74 genome-wide significant loci for TSH, of which 28 are previously unreported. Functional experiments show that the thyroglobulin protein-altering variants P118L and G67S impact thyroglobulin secretion. Phenome-wide association analysis in the UK Biobank demonstrates the pleiotropic effects of TSH-associated variants and a polygenic score for higher TSH levels is associated with a reduced risk of thyroid cancer in the UK Biobank and three other independent studies. Two-sample Mendelian randomization using TSH index variants as instrumental variables suggests a protective effect of higher TSH levels (indicating lower thyroid function) on risk of thyroid cancer and goiter. Our findings highlight the pleiotropic effects of TSH-associated variants on thyroid function and growth of malignant and benign thyroid tumors.

119,715 European ancestry individuals

Chapter III

Study Statistics

Key metrics and study information

119715
Total Participants
GWAS
Study Type
No
Replicated
European
Ancestry
Norway, U.S.
Recruitment Country
Chapter IV

Analysis

Comprehensive review of health and genetic findings

Important Disclaimer: This review has been performed semi-automatically and is provided for informational purposes only. While we strive for accuracy, this analysis may contain errors, omissions, or misinterpretations of the original research. DNA Genics disclaims all liability for any inaccuracies, errors, or consequences arising from the use of this information. Users should independently verify all information and consult original research publications before making any decisions based on this content. This analysis is not intended as a substitute for professional scientific review or medical advice.

Analysis In Progress

Our analysis of this publication is currently being prepared. Please check back soon for comprehensive insights into the health and genetic findings discussed in this research.